237 new TCM formula granule varieties in Yiling pharmaceutical

On December 7, Yiling pharmaceutical released the enterprise announcement that it received the reply on approval of matters related to traditional Chinese medicine formula granules of Shijiazhuang Yiling Pharmaceutical Co., Ltd from Hebei drug administration on December 5, 2019 It is agreed that Yiling Pharmaceutical Co., Ltd applies for the addition of 237 varieties of traditional Chinese medicine formula granules such as Acorus tatarinowii The company shall organize production in strict accordance with the technology and quality standards approved by the expert technical review It is agreed that Yiling pharmaceutical will carry out 646 kinds of traditional Chinese medicine formula granules clinical research and use in medical institutions of Hebei Province, with a trial period of one year According to the announcement, on December 26, 2018, Hebei Drug Administration agreed to carry out clinical research on 409 kinds of traditional Chinese medicine formula granules of Yiling Pharmaceutical Co., Ltd in hospitals above grade II-A (including grade II-A) in Hebei Province In addition to the 237 new approved varieties, Yiling pharmaceutical has been approved 646 traditional Chinese medicine formula granule varieties in total, and the scope of clinical research has also been expanded from the original "Hebei second class A (including second class a) and above hospitals" to "Hebei medical institutions" This time, Yiling pharmaceutical was approved to add new varieties of traditional Chinese medicine formula granules and expand the scope of clinical research, which is conducive to the company's expansion of the layout of traditional Chinese medicine industry chain, improvement of product structure, meeting market demand and further expansion of brand effect and market share, construction of new profit growth point of the company, and further improvement of the company's performance At the same time, the announcement shows that Yiling pharmaceutical industry will go through the relevant drug administration procedures such as production and variety filing as soon as possible according to the regulations, utilize the brand advantages of traditional Chinese medicine accumulated over the years, integrate industry resources, and actively promote the clinical research and market promotion of traditional Chinese medicine formula granules Yiling pharmaceutical said: at present, China's traditional Chinese medicine formula granules are still in the pilot stage, and Yiling pharmaceutical's traditional Chinese medicine formula granules business is greatly affected by the relevant national pharmaceutical policies and regulations Relying on the existing patent promotion network of traditional Chinese medicine, the company will promote the scientific research and promotion of its traditional Chinese medicine formula granule products in medical institutions of Hebei Province, and actively take measures to deal with the risks brought by changes in policies, regulations and market environment, so that its traditional Chinese medicine formula granule business can develop steadily and rapidly 37